Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comment
. 2016 Jun;81(6):1018-20.
doi: 10.1111/bcp.12881. Epub 2016 Feb 8.

Blood-brain barrier crossing and breakthroughs in glioblastoma therapy

P Sminia  1 , B A Westerman  2
Affiliations
Comment

Blood-brain barrier crossing and breakthroughs in glioblastoma therapy

P Sminia et al. Br J Clin Pharmacol. 2016 Jun.
No abstract available

PubMed Disclaimer

Comment on

References

    1. Rundle‐Thiele D, Head R, Cosgrove L, Martin JH. Repurposing some older drugs that cross the blood–brain barrier and have potential anticancer activity to provide new treatment options for glioblastoma. Br J Clin Pharmacol 2016; 81: 199–209. - PMC - PubMed
    1. Upadhyay RK. Drug delivery systems, CNS protection, and the blood brain barrier. Biomed Res Int 2014; 2014: ID869269. - PMC - PubMed
    1. Van Tellingen O, Yetkin‐Arik B, de Gooijer MC, Wesseling P, Wurdinger T, de Vries HE. Overcoming the blood–brain tumor barrier for effective glioblastoma treatment. Drug Resist Updat 2015; 19: 1–12. - PubMed
    1. Narayan RS, Fedrigo CA, Stalpers LJ, Baumert BG, Sminia P. Targeting the Akt‐pathway to improve radiosensitivity in glioblastoma. Curr Pharm Des 2013; 19: 951–7. - PubMed
    1. Bastien JI, McNeill KA, Fine HA. Molecular characterizations of glioblastoma, targeted therapy, and clinical results to date. Cancer 2015; 121: 502–16. - PubMed

Substances

LinkOut - more resources